simendan has been researched along with Respiratory Distress Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gordon, A; McAuley, DF; O'Kane, C; Prevost, AT; Santhakumaran, S; Shankar-Hari, M | 1 |
| Ertmer, C; Morelli, A; Westphal, M | 1 |
| Carbone, I; Conti, G; De Gaetano, A; Maggiore, SM; Morelli, A; Orecchioni, A; Picchini, U; Pietropaoli, P; Rocco, M; Teboul, JL; Tritapepe, L; Vieillard-Baron, A; Westphal, M | 1 |
| Carlson, RW; Emmans, L | 1 |
1 trial(s) available for simendan and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: a pilot study.
Topics: Aged; Female; Humans; Hydrazones; Hypertension, Pulmonary; Infusions, Intravenous; Male; Oxygen; Pilot Projects; Prospective Studies; Pyridazines; Respiratory Distress Syndrome; Shock, Septic; Simendan; Stroke Volume; Systole; Vascular Resistance; Vasodilator Agents; Ventricular Dysfunction, Right | 2006 |
3 other study(ies) available for simendan and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Heterogeneity of treatment effect by baseline risk of mortality in critically ill patients: re-analysis of three recent sepsis and ARDS randomised controlled trials.
Topics: Adult; Aged; Anti-Inflammatory Agents; APACHE; Cardiotonic Agents; Critical Illness; Female; Guideline Adherence; Hospital Mortality; Humans; Hydrocortisone; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intensive Care Units; Male; Middle Aged; Randomized Controlled Trials as Topic; Respiratory Distress Syndrome; Sepsis; Simendan; Simvastatin; Treatment Outcome; Vasoconstrictor Agents; Vasopressins | 2019 |
Levo is in the air: take a deep breath!
Topics: Administration, Inhalation; Adult; Animals; Cardiotonic Agents; Disease Models, Animal; Female; Hemodynamics; Humans; Hydrazones; Multiple Organ Failure; Postoperative Complications; Pyridazines; Rats; Respiratory Distress Syndrome; Risk Factors; Shock, Septic; Simendan | 2008 |
A new horizon in the treatment of right ventricular failure and pulmonary hypertension associated with acute respiratory distress syndrome?
Topics: Humans; Hydrazones; Hypertension, Pulmonary; Pyridazines; Randomized Controlled Trials as Topic; Respiratory Distress Syndrome; Shock, Septic; Simendan; Vasodilator Agents; Ventricular Dysfunction, Right | 2006 |